Program Pascasarjana
Program Studi Ilmu Kedokteran Dasar dan Biomedis
Fakultas Kedokteran

UNIVERSITAS GADJAH MADA

dr. Jarir At Thobari, PhD

 

PENDIDIKAN 

  1. S1 : Fakultas Kedokteran Universitas Gadjah Mada Yogyakarta (1997)
  2. S2 :Master Programa in Hospital Management in University of New South Wales (UNSW),  Australia (1993)                                                                                                                                                                         
  3. S3 : Doctor Degree (PhD) at Department of Pharmaco-epidemiology, Pharmacoeconomy and Pharmaco-therapy. Groningen University Institute for Drugs Exploration (GUIDE), Groningen University, the Netherlands (2006)

PENELITIAN

  1. Genetic Marker as a Predictor for Severe Cutaneus Acute Drug Reaction (G-SCAR) in Indonesia: Clinical Epidemiology & Economic Perspective. 2016-on going.
  2. Pharmacoeconomy on Antithrombotic Agent Ticagrelor for prevention Acute Coronary Syndrome. 2015-on going
  3. Pharmacovigilance of TB, HIV and malaria drugs. 2014-on going.
  4. Dry Blood Spot Validation for Therapeutic Drug Monitoring in Tuberculosis Patients in Indonesia (collaboration with Department of Pharmacy, University Medical Centre Groningen/UMCG, the Netherlands) .2013-on going
  5. RV3 Rotavirus Vaccine Clinical trial Phase IIB and III in Indonesia .2011-on going
  6. Mapping on WHO-ATC DDD Project (collaboration with Department of Pharmacy, University Medical Centre Groningen/UMCG, the Netherlands and World Health Organization). 2014-2015.
  7. Acceptability, knowledge and perspective on rotavirus vaccine (collaboration with University of New South Wales/UNSW dan Glaxo Smith Kleine/GSK). 2013-2015.
  8. Pharmacovigilance & Pharmacogenetics of anti tuberculosis drugs. 2012-2015.
  9. Pharmacoeconomy Rivaroxaban – anti arrhytmia to prevent stroke. 2012-2015.
  10. Cost of illness of antidiabetic in Indonesian. 2012 -2013.
  11. Cost effectiveness of cancre treatment in National Cancer Hospital Indonesia. 2011-2013.
  12. Pharmacoeconomy of Stroke, Cancer and Penumonia - Indonesian Hospital Study. 2012-2013.
  13. Pharmacogenetic of Cancer therapy in Indonesia (collaboration with Department of Pharmacogenetics, Leiden University Medical Centre/LUMC, the Netherlands). 2010-2012.
  14. Pharmacoeconomy evaluation of antiemetic drugs in Cancer Patients in Indonesia. 2008-2010.
  15. Drug utilization study in primary health care Tarakan, Kalimantan (funding from Ministry of Health, Indonesia). 2009.
  16. Quality prescribing on cardiovascular drugs using Indonesian hospital registration database (Funding from Faculty of Medicine, Gadjah Mada University). 2008.
  17. Drug utilization study in Krakatau Medika Hospital, Indonesia (Funding PT Persero Krakatau Steel Indonesia).2008.
  18. Impact of clinical pathway on clinical management in general hospital (Djasamen Saragih Hospital, North Sumatera). 2007-2009.
  19. Effect alert system on e-prescribing in managed mare: a quasi experimental (Pertamina Hospital, Jakarta, Indonesia). 2007-2008.
  20. Tuberculosis drugs prescribing in Indonesia (WHO funding). 2007-2008.
  21. Prevention Vascular End-stage Renal Disease (PREVEND) study in the Netherlands (Internal Medicine Department, University Medical Center Groningen & Department of Pharmacoepidemiology and Pharmacoeconomy. University of Groningen, the Netherlands). 2002-2006.
  22. Medication error due to inappropriate treatment in Tyroleans Hospital Innsbruck (Institute of Biochemical and Pharmacology, Faculty of Medicine, Franz Leopold University, Innsbruck, Austria). 2001-2002.

 

PUBLIKASI

Publikasi
Tahun
Jurnal
Penulis
Therapeutic Drug Monitoring of Antituberculosis in Indonesian Tuberculosis Patients.  2016 Value in Health Regional Issues
Perwitasari D, armawan E, Izzati U, Mulyani UA,  Atthobari J
CYP2E1 polymorphism, acetylator profile and DILI incidence of Indonesian tuberculosis patients.   2016 Asian J. Pharmaceutical Sci.
Perwitasari D, Irham LM,  Darmawan E, Mulyani UA, Atthobari J
Knowledge and attitudes towards rotavirus diarrhea and the vaccine amongst healthcare providers in Yogyakarta Indonesia.
 2016 BMC Health Services Research Holly Seale,  Sitaresmi MN, Atthobari J,Heywood AE, Kaur R, MacIntyre CR,Soenarto Y, Padmawati RS
Diagnosis of neglected tropical diseases among patients with persistent digestive disorders (diarrhoea and/or abdominal pain ≥14 days): Pierrea multi-country, prospective, non-experimental casecontrol study
 2015  BMC Infectious Disease
Polman K, Becker SL, Alirol E, Bhatta NK, Bhattarai NR, Bottieau E, Bratschi MW, Burza S, Coulibaly JT, Doumbia MN, Horié NS, Jacobs J, Khanal B, Landouré A, Mahendradhata Y, Meheus F, Mertens P, Meyanti F, Murhandarwati EH, N'Goran EK, Peeling RW, Ravinetto R, Rijal S, Sacko M, Saye R, Schneeberger PH, Schurmans C, Silué KD, Atthobari J, Traoré MS, van Lieshout L, van Loen H, Verdonck K, von Müller L, Yansouni CP, Yao JA, Yao PK, Yap P, Boelaert M, Chappuis F, Utzinger J.
Systematic review of Pharmacogenetics on isoanazid-induced hepatotoxicity
2015
Drug Metab Rev. Perwitasari DA, Atthobari J, Wilffert B.
Red sorrel (Hibiscus Sabdariffa) prevents the ethanol-induced deficits of Purkinje cells in the cerebellum.   2015 Bratisl Lek Listy
Suryanti S, Partadiredja G, Atthobari J
The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspective.
2015
Expert Rev Vaccines
Setiawan D, Luttjeboer J, Westra TA, Wilschut JC, Suwantika AA, Daemen T, Atthobari J, Wilffert B, Postma MJ.
Knowledge, perception and acceptability of rotavirus vaccine among religion, community leaders and health caders in Indonesia: a qualitative study
2015
 Vaccine
Seale H, Sitaresmi MN, Atthobari J, Heywood A, MacIntyre R, Soenarto Y, Padmawati S.
 Knowledge, perception and acceptability of rotavirus vaccine among religion, community leaders and health caders in Indonesia: a qualitative study  2015 Vaccine
Padmawati S, Heywood A, Sitaresmi MN, Atthobari J, MacIntyre R, Soenarto Y, Seale H.
Knowledge, perception and acceptability of rotavirus accine among pregnant women and caregivers in Indonesia: a qualitative study
 2015 Vaccine
Sitaresmi MN, Seale H, Heywood A, Padmawati S, MacIntyre R, Soenarto Y, Atthobari J.
Predictors of Unachieved LDL Levels in Ischemic Stroke Patients Treated with Statins in Yogyakarta Indonesia
2014
Journal of Applied Pharmaceutical Science
Rumi A, Atthobari J, Pinson R, Nugroho AR.
Polymorphims of organic cation transporter 1 (OCT1) in Indonesian Cancer Patients
2014
International Journal of Pharmacy and Pharmaceutical Science
Perwitasari DA, Atthobari J
Acetylation phenotype and drug induced hepatotoxicity among treated tuberculosis children
 2013 Pharmacoepidemiology and drug safety
 Atthobari J
Predictor of the use of gastroprotective agents in patients using NSAID in Yogyakarta, Indonesia   2012 Indonesian Journal of Pharmacy
 Indrianto AB, Atthobari J, Nugroho AE.
Impact of chemotherapy-induced nausea and vomiting on quality of life in Indonesian patients with gynecologic cancer
2012
International Journal Gynecologyogy Cancer.  Perwitasari DA, Atthobari J, Mustofa M, Dwiprahasto I, et al.
Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics
2012
International Journal Clinical Pharmacology   Perwitasari DA, Atthobari J, Gelderblom H, et al
Translation and Validation of EORTC QLQ-C30 into Indonesian Version for Cancer Patients in Indonesia
2011
Japan Journal of Clinical Oncology  Perwitasari DA, Atthobari J, Dwiprahasto I et al.
The effect of withdrawal of rofecoxib to the use of NSIDs.
 2010 Pharmacoepidemiology and drug safety  Atthobari J, Boersma C, Visser ST, et al.
Drug utilization study of gastro protective agents on NSAID/COX-2 Selective Inhibitors Users.
2009
Pharmacoepidemiology and drug safety
Atthobari J, Kristin E, Dwiprahasto I.
Quality prescribing of antihypertensive drugs in Indonesian hospitals.
 2009 Pharmacoepidemiology and drug safety
Atthobari J, Kristin E, Dwiprahasto I.
Baseline albuminuria predicts the efficacy of antihypertensive in preventing cardiovascular events.   2008 British Journal Clinical Pharmacology
Boersma C, Atthobari J, Postma MJ, et al.
The effect of screening for cardio-renal risk factors on drug use in the general population.
 2007 British Journal Clinical Pharmacology  Atthobari J, Gansevoort RT, Visser ST et al.
An economic assessment of losartanbased versus atenolol-based therapy in patients with hypertension and leftventricular hyperthrophy : results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to the Netherlands.
2007
Clinical Therapeutics
Boersma C, Atthobari J, Carides GW, et al.
Corticosteroid-induced osteoporosis prevention: longitudinal practice patterns in Netherlands 2001-2005.   2007 Journal of Osteoporosis International
Duyvendak M, Atthobari J, Naunton M, et al.
The effect of hormonal contraceptive on blood pressure, urinary albumin excretion and glomerular filtration rate.
2007
British Journal Clinical Pharmacolology  Atthobari J, Gansevoort RT, Visser ST et al.
What predicts progression and regression of urinary albumin excretion in the nondiabetic population?
 2007 Journal of American Society of NephrologyFeb; 18(2):637-45.
JBrantsma AH, Atthobari J, Bakker SJ et al.
Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making.
2006
Pharmacoeconomics Boersma C, Atthobari J, Gansevoort RT et al,
The effect of statins on urinary albumin excretion and lomerular filtration rate: an RCT and an observational cohort study.
 2006 Nephrology Dialisis & Transplantation
Atthobari J, Brantsma AH, Gansevoort RT et al,
Cost effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A harmacoeconomic analysis with an ACE -inhibitor: an Pharmacoeconomic analysis.  2006
Journal Clinical Therapeutic
Atthobari J, Asselbergs FW, Boersma C et al,
 Adherence of harmacoeconomic studies to national guidelines in the Netherlands.
2006
Pharmacy World & Science
Atthobari J, Bos JM, Boersma C et al,
Effect of hypertension and hyercholesterolemia screening with subsequent intervention letter on the use of blood ressure and lipid lowering drugs.
2006
British Journal Clinical Pharmacology
Atthobari J, Monster TB, de Jong PE et al,
Kembali